Metabolic phenotype-microRNA data fusion analysis of the systemic consequences of Roux-en-Y gastric bypass surgery

International Journal of Obesity

Volumn 39, Issue 7, 2015, Pages 1126-1134

  Wu, Q ^a   Li, J V ^a   Seyfried, F ^b   Le Roux, C W ^a,c   Ashrafian, H ^a   Athanasiou, T ^a   Fenske, W ^b   Darzi, A ^a   Nicholson, J K ^a   Holmes, E ^a   Gooderham, N J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL HORMONE; GLUCOSE; GUANINE NUCLEOTIDE BINDING PROTEIN; MICRORNA; MICRORNA 122; PENTOSE PHOSPHATE; TRICARBOXYLIC ACID; GLUCOSE BLOOD LEVEL; NEUROPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; ENERGY METABOLISM; FATTY ACID OXIDATION; GLUCONEOGENESIS; GLUCOSE TRANSPORT; GLYCOLYSIS; IN VIVO STUDY; INTESTINE FLORA; MALE; METABOLITE; METABOLOME; MODULATION; NONHUMAN; PENTOSE PHOSPHATE CYCLE; PHENOTYPE; PRIORITY JOURNAL; RAT; ROUX Y ANASTOMOSIS; SIGNAL TRANSDUCTION; STOMACH BYPASS; SYSTEMS BIOLOGY; ANIMAL; DISEASE MODEL; GLUCOSE BLOOD LEVEL; METABOLISM; OBESITY; PROCEDURES; SPRAGUE DAWLEY RAT; WEIGHT REDUCTION;

RATTUS;

ANASTOMOSIS, ROUX-EN-Y; ANIMALS; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; GASTROINTESTINAL HORMONES; MALE; MICRORNAS; NEUROPEPTIDES; OBESITY; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; WEIGHT LOSS;

EID: 84936846620     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2015.33     Document Type: Article

References (34)

1. Yach D, Stuckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 2006; 12: 62-66.
2. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737.
3. Stylopoulos N, Hoppin AG, Kaplan LM. Rouxen Y Gastric Bypass enhances energy expenditure and extends lifespan in diet induced obese rats. Obesity 2009; 17: 1839-1847.
4. Ashrafian H, Bueter M, Ahmed K, Suliman A, Bloom SR, Darzi A et al. Metabolic surgery: an evolution through bariatric animal models. Obes Rev 2010; 11: 907-920.
5. Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y et al. Human gut microbiota in obesity and after gastric bypass. PNAS 2009; 106: 2365-2370.
6. Li JV, Ashrafian H, Bueter M, Kinross J, Sands C, le Roux CW et al. Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut 2011; 60: 1214-1223.
7. Guijarro A, Osei-Hyiaman D, Harvey-White J, Kunos G, Suzuki S, Nadtochiy S et al. Sustained weight loss after roux-en-y gastric bypass is characterized by down regulation of endocannabinoids and mitochondrial function. Ann Surg 2008; 247: 779-790.
8. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-531.
9. Ebert MS, Sharp PA. Roles for microRNAs in conferring robustness to biological processes. Cell 2012; 149: 515-524.
10. Crockford DJ, Holmes E, Lindon JC, Plumb RS, Zirah S, Bruce SJ et al. Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies. Anal Chem 2006; 78: 363-371.
11. Roux CWL, Aylwin SJB, Batterham RL, Borg CM, Coyle F, Prasad V et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006; 243: 108-114.
12. Seyfried F, Li JV, Miras AD, Cluny NL, Lannoo M, Fenske WK et al. Urinary phenotyping indicates weight loss-independent metabolic effects of Roux-en-Y gastric bypass in mice. J Proteome Res 2013; 12: 1245-1253.
13. Ortega FJ, Mercader JM, Catalán V, Moreno-Navarrete JM, Pueyo N, Sabater M et al. Targeting the circulating microRNA signature of obesity. Clin Chem 2013; 59: 781-792.
14. Wallace K, Fairhall EA, Charlton KA, Wright MC. AR42J-B-13 cell: an expandable progenitor to generate an unlimited supply of functional hepatocytes. Toxicology 2010; 278: 277-287.
15. Hardie DG. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes 2008; 32: S7-S12.
16. Mitchelhill KI, Michell BJ, House CM, Stapleton D, Dyck J, Gamble J et al. Posttranslational modifications of the 5'-AMP-activated protein kinase beta1 subunit. J Biol Chem 1997; 272: 24475-24479.
17. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol 2011; 8: 467-477.
18. Chen H, Zhang SM, Hernán MA, Willett WC, Ascherio A. Weight loss in Parkinson's disease. Ann Neurol 2003; 53: 676-679.
19. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2003; 2: 107-116.
20. Ashrafian H, Harling L, Darzi A, Athanasiou T. Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions? Metab Brain Dis 2013; 28: 341-353.
21. Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008; 452: 896-U10.
22. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006; 3: 87-98.
23. Elmén J, Lindow M, Silahtaroglu A, Bak M, Christensen M, Lind-Thomsen A et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 2008; 36: 1153-1162.
24. Mencarelli A, Renga B, D'Amore C, Santorelli C, Graziosi L, Bruno A et al. Dissociation of intestinal and hepatic activities of FXR and LXR? supports metabolic effects of terminal ileum interposition in rodents. Diabetes 2013; 62: 3384-3393.
25. Saeidi N, Meoli L, Nestoridi E, Gupta NK, Kvas S, Kucharczyk J et al. Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science 2013; 341: 406-410.
26. Zhang C-Y, Baffy G, Perret P, Krauss S, Peroni O, Grujic D et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, ? cell dysfunction, and type 2 diabetes. Cell 2001; 105: 745-755.
27. Bechmann I, Diano S, Warden CH, Bartfai T, Nitsch R, Horvath TL. Brain mitochondrial uncoupling protein 2 (UCP2): a protective stress signal in neuronal injury. Biochem Pharmacol 2002; 64: 363-367.
28. Johansson L, Roos M, Kullberg J, Weis J, Ahlström H, Sundbom M et al. Lipid mobilization following Roux-en-Y gastric bypass examined by magnetic resonance imaging and spectroscopy. Obes Surg 2008; 18: 1297-1304.
29. Mattiasson G, Sullivan PG. The emerging functions of UCP2 in health, disease, and therapeutics. Antioxid Redox Signal 2006; 8: 1-38.
30. Castro MC, Massa ML, Del Zotto H, Gagliardino JJ, Francini F. Rat liver uncoupling protein 2: changes induced by a fructose-rich diet. Life Sci 2011; 89: 609-614.
31. Collins P, Jones C, Choudhury S, Damelin L, Hodgson H. Increased expression of uncoupling protein 2 in HepG2 cells attenuates oxidative damage and apoptosis. Liver Int 2005; 25: 880-887.
32. Patterson AD, Shah YM, Matsubara T, Krausz KW, Gonzalez FJ. Peroxisome proliferator activated receptor alpha induction of uncoupling protein 2 protects against acetaminophen induced liver toxicity. Hepatology 2012; 56: 281-290.
33. Ueda Y, Hajri T, Peng D, Marks-Shulman PA, Tamboli RA, Shukrallah B et al. Reduction of 8-iso-prostaglandin F2 in the first week after Roux-en-Y gastric bypass surgery. Obesity 2011; 19: 1663-1668.
34. Huang H, Kasumov T, Gatmaitan P, Heneghan HM, Kashyap SR, Schauer PR et al. Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients. Obesity 2011; 19: 2235-2240.